{"id":114214,"date":"2026-08-27T00:15:30","date_gmt":"2026-08-26T22:15:30","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=114214"},"modified":"2026-08-26T08:44:16","modified_gmt":"2026-08-26T06:44:16","slug":"uplatky-provize-a-zfalsovane-vysledky-vyzkumu-studie-odhaluje-temnou-stranku-farmaceutickeho-prumyslu","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2026\/08\/27\/uplatky-provize-a-zfalsovane-vysledky-vyzkumu-studie-odhaluje-temnou-stranku-farmaceutickeho-prumyslu\/","title":{"rendered":"\u00daplatky, provize a zfal\u0161ovan\u00e9 v\u00fdsledky v\u00fdzkumu: Studie odhaluje temnou str\u00e1nku farmaceutick\u00e9ho pr\u016fmyslu"},"content":{"rendered":"
<\/div>\n
\n
\n

Pozoruhodn\u00e1 studie zve\u0159ejn\u011bn\u00e1 za\u010d\u00e1tkem tohoto roku vrhla dal\u0161\u00ed sv\u011btlo na str\u00e1nku farmaceutick\u00e9ho pr\u016fmyslu, kter\u00e9 se mainstreamov\u00fdch m\u00e9di\u00ed i nad\u00e1le v\u011bnuje pozoruhodn\u011b m\u00e1lo pozornosti: \u00famysln\u00e9 vyu\u017e\u00edv\u00e1n\u00ed \u00faplatk\u00e1\u0159stv\u00ed a dal\u0161\u00edch korup\u010dn\u00edch praktik ke zv\u00fd\u0161en\u00ed prodeje l\u00e9k\u016f, ovliv\u0148ov\u00e1n\u00ed postup\u016f p\u0159edepisov\u00e1n\u00ed a zaji\u0161t\u011bn\u00ed preferen\u010dn\u00edho zach\u00e1zen\u00ed ze strany vl\u00e1d a regula\u010dn\u00edch org\u00e1n\u016f.\u00a0<\/span><\/strong>Studie, publikovan\u00e1 online nakladatelstv\u00edm Cambridge University Press v \u00fanoru 2026,<\/span><\/a><\/strong>\u00a0zkoumala p\u0159\u00edpady farmaceutick\u00e9ho \u00faplatk\u00e1\u0159stv\u00ed\u00a0<\/span><\/strong>zdokumentovan\u00e9 ve\u00a0<\/strong><\/span>zpr\u00e1v\u00e1ch OECD za v\u00edce ne\u017e 25 let.<\/span><\/a><\/strong><\/p>\n

Z\u00a0zpr\u00e1v publikovan\u00fdch v\u00a0letech 1999 a\u017e 2025 v\u011bdci identifikovali 21 studi\u00ed zahrnuj\u00edc\u00edch 19 farmaceutick\u00fdch spole\u010dnost\u00ed. Mezi v\u00fdslovn\u011b jmenovan\u00fdmi spole\u010dnostmi byli n\u011bkte\u0159\u00ed z\u00a0nejv\u011bt\u0161\u00edch sv\u011btov\u00fdch v\u00fdrobc\u016f l\u00e9\u010div, jako nap\u0159\u00edklad Novartis, Johnson & Johnson, Pfizer, Teva, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Sanofi a\u00a0Novo Nordisk.<\/span><\/p>\n

Zji\u0161t\u011bn\u00ed lze jen st\u011b\u017e\u00ed zavrhnout jako jedn\u00e1n\u00ed n\u011bkolika bezskrupul\u00f3zn\u00edch zam\u011bstnanc\u016f. Podle v\u00fdzkumn\u00edk\u016f bylo \u00faplatk\u00e1\u0159stv\u00ed \u010dasto povolov\u00e1no nebo v\u011bdom\u011b tolerov\u00e1no vedouc\u00edmi pracovn\u00edky, zat\u00edmco dce\u0159in\u00e9 spole\u010dnosti, extern\u00ed dodavatel\u00e9 a slo\u017eit\u00e9 podnikov\u00e9 struktury byly opakovan\u011b vyu\u017e\u00edv\u00e1ny k zatajov\u00e1n\u00ed plateb. Zdokumentovan\u00e9 \u00faplatk\u00e1\u0159sk\u00e9 praktiky trvaly v pr\u016fm\u011bru t\u00e9m\u011b\u0159 p\u011bt let, p\u0159i\u010dem\u017e nejdel\u0161\u00ed trvaly p\u0159es 11 let. Celkem byly v doty\u010dn\u00fdch p\u0159\u00edpadech odhaleny neleg\u00e1ln\u00ed platby ve v\u00fd\u0161i nejm\u00e9n\u011b 12,6 milionu dolar\u016f a vedly k finan\u010dn\u00edm pokut\u00e1m p\u0159esahuj\u00edc\u00edm 1,1 miliardy dolar\u016f.<\/span><\/p>\n

Takto fungovaly \u00faplatk\u00e1\u0159sk\u00e9 praktiky<\/span><\/strong><\/h3>\n

Studie poskytuje znepokojiv\u00fd seznam metod \u00fadajn\u011b pou\u017e\u00edvan\u00fdch k zatajen\u00ed korup\u010dn\u00edch plateb. L\u00e9ka\u0159\u016fm a dal\u0161\u00edm zdravotnick\u00fdm pracovn\u00edk\u016fm byly nab\u00edzeny luxusn\u00ed z\u00e1jezdy, d\u00e1rky, z\u00e1bava a dal\u0161\u00ed v\u00fdhody. V n\u011bkter\u00fdch p\u0159\u00edpadech farmaceuti\u010dt\u00ed z\u00e1stupci pe\u010dliv\u011b sledovali objem p\u0159edepisovan\u00fdch l\u00e9k\u016f l\u00e9ka\u0159i, aby zjistili, zda pen\u00edze a v\u00fdhody generuj\u00ed po\u017eadovan\u00e9 v\u00fdnosy. Spole\u010dnost Novartis nap\u0159\u00edklad sponzorovala \u00fa\u010dast l\u00e9ka\u0159\u016f na mezin\u00e1rodn\u00edch konferenc\u00edch, ale podle zpr\u00e1vy, kterou v\u011bdci prostudovali, pohrozila, \u017ee tuto podporu zastav\u00ed, pokud nebudou spln\u011bny c\u00edle v oblasti p\u0159edepisov\u00e1n\u00ed. Dal\u0161\u00edmi p\u0159\u00edklady byly rodinn\u00e9 dovolen\u00e9, ly\u017ea\u0159sk\u00e9 z\u00e1jezdy, pozn\u00e1vac\u00ed z\u00e1jezdy a luxusn\u00ed zbo\u017e\u00ed.<\/span><\/p>\n

Je\u0161t\u011b znepokojiv\u011bj\u0161\u00ed byla mo\u017en\u00e1 skute\u010dn\u00e1 manipulace s l\u00e9ka\u0159sk\u00fdm v\u00fdzkumem. Studie identifikovala p\u0159\u00edpady, kdy \u00fadajn\u011b v\u011bdeck\u00e9 studie byly \u00fadajn\u011b nastaveny prim\u00e1rn\u011b jako mechanismy pro placen\u00ed l\u00e9ka\u0159\u016f. N\u011bkter\u00e9 byly prezentov\u00e1ny jako studie f\u00e1ze IV, observa\u010dn\u00ed nebo epidemiologick\u00e9 studie, a\u010dkoli jejich skute\u010dn\u00fdm \u00fa\u010delem bylo propagovat konkr\u00e9tn\u00ed l\u00e9ky nebo odm\u011b\u0148ovat l\u00e9ka\u0159e, kte\u0159\u00ed je p\u0159edepisovali. V jednom p\u0159\u00edpad\u011b byla klinick\u00e1 studie pou\u017eita k propagaci l\u00e9ku Lucentis \u2013 l\u00e9ku na p\u0159edpis, kter\u00fd se injek\u010dn\u011b aplikuje do oka a jeho\u017e d\u00e1vka m\u016f\u017ee ve Spojen\u00fdch st\u00e1tech st\u00e1t kolem 2 000 dolar\u016f \u2013 sp\u00ed\u0161e ne\u017e k proveden\u00ed skute\u010dn\u00e9ho v\u00fdzkumu; v jin\u00e9m p\u0159\u00edpad\u011b byly platby poskytov\u00e1ny prost\u0159ednictv\u00edm fale\u0161n\u00e9 neurov\u011bdeck\u00e9 studie.<\/span><\/p>\n

Dal\u0161\u00ed b\u011b\u017en\u011b pou\u017e\u00edvanou technikou bylo zam\u011bstn\u00e1v\u00e1n\u00ed l\u00e9ka\u0159\u016f nebo vl\u00e1dn\u00edch \u00fa\u0159edn\u00edk\u016f jako \u00fadajn\u00fdch \u201ekonzultant\u016f\u201c, \u201e\u0159e\u010dn\u00edk\u016f\u201c nebo \u201ekl\u00ed\u010dov\u00fdch v\u016fdc\u016f ve\u0159ejn\u00e9ho m\u00edn\u011bn\u00ed\u201c. V\u00fdzkumn\u00edci zjistili p\u0159\u00edpady, kdy jednotlivci dost\u00e1vali zna\u010dn\u00e9 platby za m\u00e1lo nebo \u017e\u00e1dnou skute\u010dnou pr\u00e1ci, p\u0159i\u010dem\u017e pen\u00edze byly zaznamen\u00e1ny jako konzulta\u010dn\u00ed, expertn\u00ed nebo poradensk\u00e9 poplatky. V jednom obzvl\u00e1\u0161t\u011b do o\u010d\u00ed bij\u00edc\u00edm p\u0159\u00edpad\u011b vysoce postaven\u00fd ukrajinsk\u00fd zdravotnick\u00fd \u00fa\u0159edn\u00edk dost\u00e1val 200 000 dolar\u016f m\u011bs\u00ed\u010dn\u011b na \u00fadajn\u00fdch konzulta\u010dn\u00edch poplatc\u00edch.<\/span><\/p>\n

N\u011bkter\u00e9 z t\u011bchto sch\u00e9mat byly je\u0161t\u011b sofistikovan\u011bj\u0161\u00ed. Farmaceutick\u00e9 spole\u010dnosti vyu\u017e\u00edvaly distributory, offshore firmy a fiktivn\u00ed spole\u010dnosti k maskov\u00e1n\u00ed plateb, zat\u00edmco pad\u011blan\u00e9 faktury uv\u00e1d\u011bly pen\u00edze jako platby za reklamu, skladov\u00e1n\u00ed, marketing, poradenstv\u00ed nebo jin\u00e9 legitimn\u00ed slu\u017eby. V\u00fdzkumn\u00edci uv\u00e1d\u011bj\u00ed jeden p\u0159\u00edpad, kdy rusk\u00e1 pobo\u010dka spole\u010dnosti Eli Lilly uzav\u0159ela 96 fiktivn\u00edch marketingov\u00fdch nebo servisn\u00edch smluv se 42 offshore spole\u010dnostmi a nakonec \u00fa\u0159edn\u00edk\u016fm vyplatila v\u00edce ne\u017e 11 milion\u016f dolar\u016f.<\/span><\/p>\n

Kdy\u017e se \u00faplatk\u00e1\u0159stv\u00ed dostane k regula\u010dn\u00edm org\u00e1n\u016fm<\/span><\/strong><\/h3>\n

D\u016fsledky jsou obzvl\u00e1\u0161t\u011b z\u00e1va\u017en\u00e9, kdy\u017e se korup\u010dn\u00ed platby pou\u017e\u00edvaj\u00ed nejen k p\u0159im\u011bt\u00ed l\u00e9ka\u0159\u016f k p\u0159edeps\u00e1n\u00ed konkr\u00e9tn\u00edho l\u00e9ku, ale tak\u00e9 k ovliv\u0148ov\u00e1n\u00ed schvalovac\u00edch a zad\u00e1vac\u00edch rozhodnut\u00ed, kter\u00e1 ur\u010duj\u00ed, kter\u00e9 l\u00e9ky v\u016fbec vstoup\u00ed do syst\u00e9mu zdravotn\u00ed p\u00e9\u010de. Studie odhalila p\u0159\u00edpady, kdy farmaceutick\u00e9 spole\u010dnosti \u00fadajn\u011b podpl\u00e1cely \u00fa\u0159edn\u00edky nebo vyu\u017e\u00edvaly zprost\u0159edkovatele k urychlen\u00ed regula\u010dn\u00edch schv\u00e1len\u00ed, z\u00edsk\u00e1n\u00ed certifikac\u00ed produkt\u016f nebo zaji\u0161t\u011bn\u00ed smluv s ve\u0159ejn\u00fdmi nemocnicemi. Tyto praktiky se zam\u011b\u0159ily na ministerstva zdravotnictv\u00ed, zad\u00e1vac\u00ed agentury a vl\u00e1dn\u00ed poji\u0161\u0165ovac\u00ed programy.<\/span><\/p>\n

V\u00fdzkumn\u00edci tak\u00e9 identifikovali p\u0159\u00edpady \u00faplatk\u00e1\u0159stv\u00ed ve farmaceutick\u00e9m pr\u016fmyslu spojen\u00e9 s programem OSN \u201eRopa za potraviny\u201c v Ir\u00e1ku. Spole\u010dnosti manipulovaly smluvn\u00edmi cenami a maskovaly nadsazen\u00e9 platby jako zprost\u0159edkovatelsk\u00e9 provize, p\u0159i\u010dem\u017e p\u0159ebyte\u010dn\u00e9 pen\u00edze nakonec putovaly k ir\u00e1ck\u00fdm \u00fa\u0159edn\u00edk\u016fm. Nap\u0159\u00edklad spole\u010dnost Johnson & Johnson zaplatila \u00faplatky ve v\u00fd\u0161i 857 387 dolar\u016f maskovan\u00e9 jako zprost\u0159edkovatelsk\u00e9 provize a zv\u00fd\u0161ila n\u011bkter\u00e9 ir\u00e1ck\u00e9 smlouvy o 10 procent. Spole\u010dnost Novo Nordisk zaplatila 1,44 milionu dolar\u016f a v souvislosti s t\u011bmito sch\u00e9maty schv\u00e1lila dal\u0161\u00edch 1,32 milionu dolar\u016f v nadsazen\u00fdch proviz\u00edch. V jin\u00e9m p\u0159\u00edpad\u011b spole\u010dnost Eli Lilly p\u0159evedla t\u00e9m\u011b\u0159 40 000 dolar\u016f soukrom\u00e9 nadaci spojen\u00e9 s vysoce postaven\u00fdm polsk\u00fdm \u00fa\u0159edn\u00edkem v\u00fdm\u011bnou za p\u0159\u00edzniv\u00e1 rozhodnut\u00ed o \u00fahrad\u011b l\u00e9k\u016f.<\/span><\/p>\n

Nejde jen o \u00fa\u010detn\u00ed nesrovnalosti. Pokud finan\u010dn\u00ed pob\u00eddky ovliv\u0148uj\u00ed, kter\u00e9 l\u00e9ky l\u00e9ka\u0159i p\u0159edepisuj\u00ed, kter\u00e9 l\u00e9ky vl\u00e1dy nakupuj\u00ed nebo kter\u00e9 dost\u00e1vaj\u00ed schv\u00e1len\u00ed regula\u010dn\u00edmi org\u00e1ny, m\u016f\u017ee korupce p\u0159\u00edmo ovlivnit fungov\u00e1n\u00ed syst\u00e9m\u016f zdravotn\u00ed p\u00e9\u010de.<\/span><\/p>\n

Rozsah korupce by mohl b\u00fdt mnohem v\u011bt\u0161\u00ed, ne\u017e nazna\u010duj\u00ed ofici\u00e1ln\u00ed \u010d\u00edsla<\/span><\/strong><\/h3>\n

Zji\u0161t\u011bn\u00ed studie by nem\u011bla b\u00fdt interpretov\u00e1na jako odraz cel\u00e9ho rozsahu korupce ve farmaceutick\u00e9m pr\u016fmyslu. V\u00fdzkumn\u00edci zd\u016fraz\u0148uj\u00ed, \u017ee jejich anal\u00fdza zahrnuje pouze p\u0159\u00edpady, kter\u00e9 se staly dostate\u010dn\u011b viditeln\u00fdmi, aby vy\u017eadovaly ofici\u00e1ln\u00ed vy\u0161et\u0159ov\u00e1n\u00ed a trestn\u00ed st\u00edh\u00e1n\u00ed. Spole\u010dnosti p\u016fsob\u00edc\u00ed v zem\u00edch se slab\u0161\u00edm vym\u00e1h\u00e1n\u00edm pr\u00e1va, p\u0159\u00edpady vy\u0159e\u0161en\u00e9 d\u016fv\u011brn\u011b nebo korup\u010dn\u00ed praktiky, kter\u00e9 z\u016fst\u00e1vaj\u00ed neodhalen\u00e9, se v datov\u00e9 sad\u011b neobjevuj\u00ed. Auto\u0159i proto popisuj\u00ed neviditelnou \u201eskrytou postavu\u201c korupce, kter\u00e1 nen\u00ed nikdy ofici\u00e1ln\u011b zdokumentov\u00e1na, a zd\u016fraz\u0148uj\u00ed, \u017ee dostupn\u00e9 p\u0159\u00edpady pravd\u011bpodobn\u011b podce\u0148uj\u00ed skute\u010dn\u00fd rozsah probl\u00e9mu.<\/span><\/p>\n

Studie rovn\u011b\u017e odhalila, \u017ee do dvan\u00e1cti zkouman\u00fdch p\u0159\u00edpad\u016f byly zapojeny dce\u0159in\u00e9 spole\u010dnosti. Zjistila, \u017ee vedouc\u00ed pracovn\u00edci schv\u00e1lili nadm\u011brn\u00e9 platby nebo skryt\u00e9 v\u00fddaje, zat\u00edmco intern\u00ed varov\u00e1n\u00ed a audity shody s p\u0159edpisy, a\u010dkoli n\u011bkdy odhalily zjevn\u00e9 probl\u00e9my, jim nedok\u00e1zaly zabr\u00e1nit. To vyvol\u00e1v\u00e1 z\u0159ejmou ot\u00e1zku: Kolik dal\u0161\u00edch podobn\u00fdch sch\u00e9mat z\u016fstalo neodhaleno?<\/span><\/p>\n

Co n\u00e1m to \u0159\u00edk\u00e1 o farmaceutick\u00e9m pr\u016fmyslu?<\/span><\/strong><\/h3>\n

V\u00fdznam studie sah\u00e1 daleko za jednotliv\u00e9 spole\u010dnosti a p\u0159\u00edpady, kter\u00e9 identifikuje, jeliko\u017e \u00faplatk\u00e1\u0159stv\u00ed m\u016f\u017ee naru\u0161it syst\u00e9m zdravotn\u00ed p\u00e9\u010de, i kdy\u017e je samotn\u00fd l\u00e9k pova\u017eov\u00e1n za spl\u0148uj\u00edc\u00ed ofici\u00e1ln\u00ed standardy kvality. Pokud l\u00e9ka\u0159 p\u0159edep\u00ed\u0161e konkr\u00e9tn\u00ed l\u00e9k z finan\u010dn\u00edch d\u016fvod\u016f, nikoli proto, \u017ee je \u00fadajn\u011b nejlep\u0161\u00ed volbou pro pacienta, pacient m\u016f\u017ee st\u00e1le trp\u011bt. Pokud je rozhodnut\u00ed o vl\u00e1dn\u00edch zak\u00e1zk\u00e1ch ovlivn\u011bno \u00faplatky, da\u0148ov\u00ed poplatn\u00edci mohou nakonec zaplatit v\u00edce za l\u00e9ky, kter\u00e9 nemus\u00ed b\u00fdt nutn\u011b vhodn\u00e9. A pokud jsou vl\u00e1dn\u00ed rozhodnut\u00ed ohro\u017eena, mohou b\u00fdt d\u016fsledky podstatn\u011b z\u00e1va\u017en\u011bj\u0161\u00ed.<\/span><\/p>\n

V\u00fdzkumn\u00edci v\u00fdznamn\u011b doch\u00e1zej\u00ed k z\u00e1v\u011bru, \u017ee se jedn\u00e1 o syst\u00e9mov\u00fd probl\u00e9m, kter\u00fd se neomezuje pouze na jednu zemi nebo region. P\u0159\u00edpady, kter\u00e9 uvedli, se t\u00fdkaly \u00faplatk\u00e1\u0159stv\u00ed ve 30 zem\u00edch Asie, v\u00fdchodn\u00ed Evropy, Bl\u00edzk\u00e9ho v\u00fdchodu a Latinsk\u00e9 Ameriky. To je obzvl\u00e1\u0161t\u011b d\u016fle\u017eit\u00e9 proto, \u017ee farmaceutick\u00fd pr\u016fmysl si po cel\u00e1 desetilet\u00ed p\u011bstuje obraz p\u0159\u00edsn\u011b regulovan\u00e9ho, \u200b\u200bv\u011bdecky zalo\u017een\u00e9ho odv\u011btv\u00ed, jeho\u017e hlavn\u00edm c\u00edlem je vyv\u00edjet l\u00e9ky ke zlep\u0161en\u00ed lidsk\u00e9ho zdrav\u00ed. D\u016fkazy zdokumentovan\u00e9 v t\u00e9to studii v\u0161ak odhaluj\u00ed, jak finan\u010dn\u00ed pob\u00eddky mohou pronikat do v\u00edce \u00farovn\u00ed syst\u00e9mu \u2013 od l\u00e9ka\u0159e, kter\u00fd p\u0159edepisuje l\u00e9ky, p\u0159es \u00fa\u0159edn\u00edka, kter\u00fd l\u00e9k schvaluje, a\u017e po vl\u00e1du, kter\u00e1 rozhoduje o tom, kter\u00e9 l\u00e9ky budou zakoupeny.<\/span><\/p>\n

Pro\u010d jsme o t\u00e9to studii sly\u0161eli tak m\u00e1lo?<\/span><\/strong><\/h3>\n

Snad nejpozoruhodn\u011bj\u0161\u00edm aspektem tohoto v\u00fdzkumu nen\u00ed jen to, co objevil, ale tak\u00e9 to, jak m\u00e1lo pozornosti se mu zjevn\u011b dostalo. \u010cl\u00e1nek, publikovan\u00fd online 10. \u00fanora 2026, je voln\u011b p\u0159\u00edstupn\u00fd a objevil se v \u010dasopise \u201eJournal of Law, Medicine & Ethics\u201c nakladatelstv\u00ed Cambridge University Press. Zji\u0161t\u011bn\u00ed se t\u00fdkaj\u00ed n\u011bkter\u00fdch z nejv\u011bt\u0161\u00edch sv\u011btov\u00fdch farmaceutick\u00fdch spole\u010dnost\u00ed a dokumentuj\u00ed p\u0159\u00edpady \u00faplatk\u00e1\u0159stv\u00ed l\u00e9ka\u0159\u016f, vl\u00e1dn\u00edch \u00fa\u0159edn\u00edk\u016f, regula\u010dn\u00edch org\u00e1n\u016f a syst\u00e9m\u016f ve\u0159ejn\u00fdch zak\u00e1zek. P\u0159esto se zd\u00e1, \u017ee m\u00edsto toho, aby tento p\u0159\u00edb\u011bh dominoval titulk\u016fm, byl z velk\u00e9 \u010d\u00e1sti ignorov\u00e1n.<\/span><\/p>\n

Pro to pravd\u011bpodobn\u011b existuje mnoho vysv\u011btlen\u00ed. Korupce ve farmaceutick\u00e9m pr\u016fmyslu je slo\u017eit\u00e1 a \u010dasto zahrnuje ud\u00e1losti, kter\u00e9 se staly p\u0159ed lety. Zapojen\u00e9 spole\u010dnosti ji\u017e mohly zaplatit pokuty, co\u017e umo\u017e\u0148uje prezentovat p\u0159\u00edpady jako uzav\u0159en\u00e9. A zaveden\u00e1 m\u00e9dia nepochybn\u011b soupe\u0159\u00ed o pozornost ve\u0159ejnosti s \u0159adou dal\u0161\u00edch zpr\u00e1v.<\/span><\/p>\n

Je v\u0161ak t\u0159eba si polo\u017eit je\u0161t\u011b jednu ot\u00e1zku. Farmaceutick\u00e9 spole\u010dnosti pat\u0159\u00ed mezi nejvlivn\u011bj\u0161\u00ed inzerenty na sv\u011bt\u011b a mnoho zaveden\u00fdch medi\u00e1ln\u00edch spole\u010dnost\u00ed je siln\u011b z\u00e1visl\u00fdch na komer\u010dn\u00ed reklam\u011b.<\/span><\/p>\n

Ovliv\u0148uje ale tento finan\u010dn\u00ed vztah, kter\u00e9 aspekty farmaceutick\u00e9ho pr\u016fmyslu jsou p\u0159edm\u011btem pr\u016fb\u011b\u017en\u00e9 kontroly?<\/span><\/p>\n

Samotn\u00e1 studie se touto ot\u00e1zkou nezab\u00fdv\u00e1, tak\u017ee nem\u016f\u017ee ur\u010dit, zda je za nedostatek medi\u00e1ln\u00ed pozornosti zodpov\u011bdn\u00e1 farmaceutick\u00e1 reklama. Rozpor mezi v\u00fdznamnost\u00ed zji\u0161t\u011bn\u00ed a zd\u00e1nlivou absenc\u00ed ve\u0159ejn\u00e9 diskuse v\u0161ak jist\u011b stoj\u00ed za prozkoum\u00e1n\u00ed.<\/span><\/p>\n

Pokud d\u016fkazy o \u00faplatk\u00e1\u0159stv\u00ed zahrnuj\u00edc\u00ed n\u011bkter\u00e9 z nejv\u011bt\u0161\u00edch sv\u011btov\u00fdch farmaceutick\u00fdch spole\u010dnost\u00ed nevyvolaj\u00ed \u017e\u00e1dnou v\u00fdznamnou ve\u0159ejnou debatu, co to vypov\u00edd\u00e1 o informac\u00edch, kter\u00e9 ve\u0159ejnost dost\u00e1v\u00e1 o farmaceutick\u00e9m pr\u016fmyslu?<\/span><\/p>\n

Ve\u0159ejnost m\u00e1 pr\u00e1vo to v\u011bd\u011bt<\/span><\/strong><\/h3>\n

Auto\u0159i studie volaj\u00ed po v\u011bt\u0161\u00ed transparentnosti, p\u0159\u00edsn\u011bj\u0161\u00edm dohledu, lep\u0161\u00edm monitorov\u00e1n\u00ed plateb farmaceutick\u00e9ho pr\u016fmyslu zdravotnick\u00fdm pracovn\u00edk\u016fm a lep\u0161\u00ed ochran\u011b oznamovatel\u016f. Zasazuj\u00ed se tak\u00e9 o reformy, kter\u00e9 by mohly omezit mo\u017enosti korup\u010dn\u00edch plateb, v\u010detn\u011b nez\u00e1vislej\u0161\u00edho financov\u00e1n\u00ed klinick\u00e9ho v\u00fdzkumu a men\u0161\u00ed z\u00e1vislosti regula\u010dn\u00edch org\u00e1n\u016f na financov\u00e1n\u00ed pr\u016fmyslem. To v\u0161e jsou rozumn\u00e9 n\u00e1vrhy. Jde v\u0161ak o v\u011bt\u0161\u00ed probl\u00e9m.<\/span><\/p>\n

Ve\u0159ejnost byla po l\u00e9ta povzbuzov\u00e1na k tomu, aby se na farmaceutick\u00fd pr\u016fmysl d\u00edvala p\u0159edev\u0161\u00edm optikou v\u011bdeck\u00e9ho pokroku a l\u00e9ka\u0159sk\u00fdch inovac\u00ed. Mnohem men\u0161\u00ed pozornost se v\u011bnuje jeho obrovsk\u00fdm finan\u010dn\u00edm pob\u00eddk\u00e1m a st\u0159et\u016fm z\u00e1jm\u016f, kter\u00e9 mohou vzniknout, kdy\u017e se komer\u010dn\u00ed c\u00edle st\u0159etnou s l\u00e9ka\u0159sk\u00fdmi rozhodnut\u00edmi.<\/span><\/p>\n

Studie nedokazuje, \u017ee je cel\u00fd farmaceutick\u00fd pr\u016fmysl zkorumpovan\u00fd, ani nenazna\u010duje, \u017ee ka\u017ed\u00fd l\u00e9ka\u0159, regula\u010dn\u00ed org\u00e1n nebo farmaceutick\u00fd zam\u011bstnanec jedn\u00e1 ne\u010destn\u011b. To, co v\u0161ak nab\u00edz\u00ed, je mnohem t\u011b\u017e\u0161\u00ed odm\u00edtnout: systematick\u00e9 vy\u0161et\u0159ov\u00e1n\u00ed ofici\u00e1ln\u011b zdokumentovan\u00fdch p\u0159\u00edpad\u016f, kter\u00e9 ukazuj\u00ed, \u017ee k \u00faplatk\u00e1\u0159stv\u00ed opakovan\u011b doch\u00e1zelo v r\u016fzn\u00fdch zem\u00edch, spole\u010dnostech a na r\u016fzn\u00fdch \u00farovn\u00edch farmaceutick\u00e9ho syst\u00e9mu.<\/span><\/p>\n

Auto\u0159i varuj\u00ed, \u017ee p\u0159\u00edpady, kter\u00e9 identifikovali, t\u00e9m\u011b\u0159 jist\u011b p\u0159edstavuj\u00ed pouze \u0161pi\u010dku ledovce. To by m\u011blo znepokojit ka\u017ed\u00e9ho, kdo se domn\u00edv\u00e1, \u017ee rozhodnut\u00ed o zdravotn\u00ed p\u00e9\u010di by m\u011bla b\u00fdt zalo\u017eena p\u0159edev\u0161\u00edm na jednom hledisku: Co je pro pacienta nejlep\u0161\u00ed?<\/span><\/p>\n

Pokud m\u00e1 ve\u0159ejnost d\u016fv\u011b\u0159ovat modern\u00ed medic\u00edn\u011b, m\u00e1 pr\u00e1vo v\u011bd\u011bt nejen to, co farmaceutick\u00e9 spole\u010dnosti \u0159\u00edkaj\u00ed o sob\u011b, ale tak\u00e9 to, co o jejich chov\u00e1n\u00ed odhaluje jejich zdokumentovan\u00e1 historie. Je na\u010dase \u0159\u00edct pacient\u016fm pravdu.<\/span><\/p>\n

Od Paula Anthonyho Taylora<\/span><\/em><\/strong><\/p>\n<\/div>\n<\/div>\n

\n
\n

Zdroj<\/span><\/a><\/span><\/h3>\n

 <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pozoruhodn\u00e1 studie zve\u0159ejn\u011bn\u00e1 za\u010d\u00e1tkem tohoto roku vrhla dal\u0161\u00ed sv\u011btlo na str\u00e1nku farmaceutick\u00e9ho pr\u016fmyslu, kter\u00e9 se…<\/p>\n","protected":false},"author":2,"featured_media":114215,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[949,207,2530],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/114214"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=114214"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/114214\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/114215"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=114214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=114214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=114214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}